The Use of Therapeutic-Dose Anticoagulation and Its Effect on Mortality in Patients With COVID-19: A Systematic Review
The incidence of venous thromboembolism (VTE) events in patients with COVID-19 treated with a standard thromboprophylaxis dose of anticoagulants remains high. We conducted a systematic review in order to explore the association between therapeutic-dose anticoagulation and its effect on mortality in...
Main Authors: | Indra Wijaya MD, Rizky Andhika MD, Ian Huang MD |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2020-10-01
|
Series: | Clinical and Applied Thrombosis/Hemostasis |
Online Access: | https://doi.org/10.1177/1076029620960797 |
Similar Items
-
The use of Janus Kinase inhibitors in hospitalized patients with COVID-19: Systematic review and meta-analysis
by: Indra Wijaya, et al.
Published: (2021-07-01) -
The Role of Therapeutic Anticoagulation in COVID-19
by: Ruth McGovern, et al.
Published: (2020-01-01) -
Anticoagulation and In-Hospital Mortality From Coronavirus Disease 2019: A Systematic Review and Meta-Analysis
by: Chatphatai Moonla MD, MSc, et al.
Published: (2021-04-01) -
COVID-19: Coagulopathy, Risk of Thrombosis, and the Rationale for Anticoagulation
by: Wolfgang Miesbach MD, et al.
Published: (2020-07-01) -
Effect of Anticoagulant Administration on the Mortality of Hospitalized Patients With COVID-19: An Updated Systematic Review and Meta-Analysis
by: Luojia Jiang, et al.
Published: (2021-08-01)